Webinars Posts
Webinar – Insights from Mapping API Inspection Deficiencies to the Quality Systems
Webinar – Legal Considerations | Interacting with the FDA Before, During, and After Inspections
Webinar – Quality Intelligence: from Information to Knowledge
Webinar – Comparing Inspection Observations between FDA and Health Canada
Webinar – Data Integrity and Quality Culture – Enabling far more than “just” compliance
Webinar – The Insider’s Guide to FDA Audit Readiness
Webinar – Top 10 Regulatory Surveillance Signals of Summer 2022
Webinar – A Fresh Take on Pre-Approval Inspection Data
Webinar – FDA GCP Inspection Trends Identified Using AI
Webinar – Are Laboratories Perpetuating Data Integrity Problems?
Webinar – Bringing Innovation to Regulatory Intelligence from Ideation to Success
Webinar – UDI | Aligning to a Single Approach
Webinar – Past, Present, and Future of Quality Culture
Panel Discussion – Changing Medical Device Regulations
Webinar – A.I. for Quality and Compliance Teams
Webinar – Human Factors – Compliance and Applications
Panel Discussion – Remote Audits
Webinar – Leadership SOS – Turning Failure into Success
Webinar – How to Build and Implement a QMS for Small Pharma and Biotech Firms
Webinar – The Ecosystem for Smart Combination Products
Webinar – Comparing and Analyzing Russian, UK, and US Top Ten Pharma Inspection Findings FY 2019
Webinar – Deploying Risk-Based Thinking within Management Systems
Webinar – Impact of Pandemic on Regulatory Trends
Webinar – Champion of Change – 3Cs to Success
Webinar – GMP Compliance Issues for Legacy Products
Webinar – CMC Considerations for Cell and Gene Therapy Products
Webinar – The 503B Outsourcing Story
Webinar – Assuring Inspection Success